BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30229692)

  • 1. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J; Bao J; Shi X; Sheng X; Su W
    J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
    Kini A; Patel SB
    Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
    Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
    AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
    Chen J; Qiu L; Hu M; Jin Y; Han J
    Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design.
    Kyaw Oo M; Mandal UK; Chatterjee B
    Pharm Dev Technol; 2017 Feb; 22(1):2-12. PubMed ID: 26616399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients.
    Kaur M; Mittal A; Gulati M; Sharma D; Kumar R
    Recent Pat Drug Deliv Formul; 2020; 14(1):48-62. PubMed ID: 31884935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
    Wairkar S; Gaud R; Jadhav N
    J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
    McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
    Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
    Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
    J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M; Liebenberg W; Aucamp M
    AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
    Ha ES; Choo GH; Baek IH; Kim MS
    Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
    Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
    AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.